ロード中...

Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line

Glioblastomas (GBM) are the most common grade 4 brain tumours; patients have very poor prognosis with an average survival of 15 months after diagnosis. Novel research lines have begun to explore aberrant protein arginine methylation (ArgMe) as a possible therapeutic target in GBM and ArgMe inhibitor...

詳細記述

保存先:
書誌詳細
出版年:Proteomes
主要な著者: Samuel, Sabrina Francesca, Marsden, Alistair James, Deepak, Srihari, Rivero, Francisco, Greenman, John, Beltran-Alvarez, Pedro
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6313862/
https://ncbi.nlm.nih.gov/pubmed/30347783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/proteomes6040044
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!